OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES

BACKGROUND: Due to the lack of specificity of contrast-enhanced (CE) MRI, both the response assessment and differentiation of progression from pseudoprogression (PsP) following immunotherapy using checkpoint inhibitors (ICI) or targeted therapy (TT) may be challenging, especially when ICI or TT is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Galldiks, Norbert, Abdulla, Diana, Scheffler, Matthias, Schweinsberg, Viola, Schlaak, Max, Kreuzberg, Nicole, Landsberg, Jenny, Lohmann, Philipp, Ceccon, Garry, Werner, Jan-Michael, Celik, Eren, Ruge, Maximilian, Kocher, Martin, Marnitz, Simone, Fink, Gereon, Langen, Karl-Josef, Wolf, Juergen, Mauch, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213403/
http://dx.doi.org/10.1093/noajnl/vdz014.091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213403/
http://dx.doi.org/10.1093/noajnl/vdz014.091

Ejemplares similares